← FDA Drug Approvals (Drugs@FDA)
IBANDRONATE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2016-02-05
Drug application
- FDA Application #
ANDA206058- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IBANDRONATE SODIUM
- Generic name
- Ibandronate Sodium
- Active ingredients
- IBANDRONATE SODIUM
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- ACCORD HLTHCARE
- First approval
- 2016-02-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown